A groundbreaking retinal implant, PRIMA, is restoring central vision in patients with geographic atrophy (GA), an advanced form of macular degeneration that blinds roughly 1 million Americans. Unlike ...

A Race Against Blindness (RAB) today announced the launch of its Spring 2026 national fundraiser, Two Winners, One Drive for Vision Research, in strategic partnership with the Foundation Fighting ...

Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. A new study may transform ...

For millions across the world, blindness often begins quietly, with gradual retinal damage that goes unnoticed until it is too late. Now, a new scientific breakthrough could change that future.

The trend of retinal blindness has changed its pattern over the years in developing countries. A decade ago, hereditary retinal disorders formed the major cause of visual loss due to retinal diseases.

A project at Shanghai's Fudan University has developed a new retinal prosthesis and used it to restore vision to a number of blind mice. Described in Science the implant is said to offer advantages ...

A new prosthesis for the retina weaved with nanowires partially restored vision in blind mice and allowed detection of near-infrared light in macaques, according to a new study. The new technology's ...

The MarketWatch News Department was not involved in the creation of this content. SCOTTSDALE, Ariz., March 16, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness (RAB) today announced the launch of its ...